These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7589196

  • 21. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
    Kessler RM, Whetsell WO, Ansari MS, Votaw JR, de Paulis T, Clanton JA, Schmidt DE, Mason NS, Manning RG.
    Brain Res; 1993 Apr 23; 609(1-2):237-43. PubMed ID: 8099521
    [Abstract] [Full Text] [Related]

  • 22. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
    Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M.
    Am J Psychiatry; 1998 Jun 23; 155(6):761-7. PubMed ID: 9619147
    [Abstract] [Full Text] [Related]

  • 23. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
    Yang YK, Yu L, Yeh TL, Chiu NT, Chen PS, Lee IH, SPECT study.
    Am J Psychiatry; 2004 Aug 23; 161(8):1496-8. PubMed ID: 15285982
    [Abstract] [Full Text] [Related]

  • 24. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G.
    Int J Neuropsychopharmacol; 2010 Aug 23; 13(7):951-60. PubMed ID: 20392299
    [Abstract] [Full Text] [Related]

  • 25. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL, Peron-Magnan P, Huret JD, Mazoyer B, Baron JC, Boulenger JP, Loc'h C, Maziere B, Caillard V, Loo H.
    Am J Psychiatry; 1990 Jan 23; 147(1):44-50. PubMed ID: 2293788
    [Abstract] [Full Text] [Related]

  • 26. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A.
    J Pharmacol Exp Ther; 1995 Dec 23; 275(3):1239-46. PubMed ID: 8531087
    [Abstract] [Full Text] [Related]

  • 27. A post-mortem study on striatal dopamine receptors in Parkinson's disease.
    Rinne JO, Laihinen A, Lönnberg P, Marjamäki P, Rinne UK.
    Brain Res; 1991 Aug 09; 556(1):117-22. PubMed ID: 1834312
    [Abstract] [Full Text] [Related]

  • 28. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec 09; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 30. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride.
    Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G.
    Synapse; 1996 Jun 16; 23(2):115-23. PubMed ID: 8723716
    [Abstract] [Full Text] [Related]

  • 31. D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects.
    Lahti RA, Roberts RC, Conley RR, Cochrane EV, Mutin A, Tamminga CA.
    Neuroreport; 1996 Aug 12; 7(12):1945-8. PubMed ID: 8905699
    [Abstract] [Full Text] [Related]

  • 32. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK.
    Brain; 1999 Aug 12; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [Abstract] [Full Text] [Related]

  • 33. Presence of D4 dopamine receptors in human prefrontal cortex: a postmortem study.
    Marazziti D, Lucacchini A, Baroni S, Betti L, Catena M, Giannaccini G, Dell'Osso B, Masala I, Mungai F, Dell'Osso L.
    Braz J Psychiatry; 2007 Jun 12; 29(2):148-52. PubMed ID: 17639254
    [Abstract] [Full Text] [Related]

  • 34. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.
    Murray AM, Ryoo HL, Gurevich E, Joyce JN.
    Proc Natl Acad Sci U S A; 1994 Nov 08; 91(23):11271-5. PubMed ID: 7972046
    [Abstract] [Full Text] [Related]

  • 35. Enantio- and diastereocontrolled dopamine D1, D2, D3 and D4 receptor binding of N-(3-pyrrolidinylmethyl)benzamides synthesized from aspartic acid.
    Thomas C, Hübner H, Gmeiner P.
    Bioorg Med Chem Lett; 1999 Mar 22; 9(6):841-6. PubMed ID: 10206547
    [Abstract] [Full Text] [Related]

  • 36. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
    Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ.
    Arch Gen Psychiatry; 1997 Dec 22; 54(12):1089-95. PubMed ID: 9400344
    [Abstract] [Full Text] [Related]

  • 37. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK.
    J Pharmacol Exp Ther; 1992 Jun 22; 261(3):1282-90. PubMed ID: 1534844
    [Abstract] [Full Text] [Related]

  • 38. D4 receptors and schizophrenia.
    Strange PG, Vile JM.
    J Neurochem; 1995 Nov 22; 65(5):2381-3. PubMed ID: 7595530
    [No Abstract] [Full Text] [Related]

  • 39. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A.
    Psychopharmacology (Berl); 2004 Oct 22; 175(4):473-80. PubMed ID: 15083259
    [Abstract] [Full Text] [Related]

  • 40. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
    Lomeña F, Catafau AM, Parellada E, Bernardo M, Font M, Gutiérrez F, Pavía J.
    Psychopharmacology (Berl); 2004 Mar 22; 172(2):165-9. PubMed ID: 14624330
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.